Roland Griffiths, a pioneering psychedelic researcher, discusses how psilocybin can ease the fear of death, especially in terminal patients. Lou Lukas, a palliative medicine physician, shares insights on integrating psychedelic therapy into end-of-life care. Anthony Bossis, a clinical psychologist, highlights the transformative, mystical experiences that psychedelics evoke, reshaping perceptions of mortality. Together, they explore how psychedelics can foster acceptance, alleviate existential anxiety, and encourage meaningful discussions about life and legacy.

Dr. Anthony Bossis, a clinical assistant professor at NYU School of Medicine, explores the therapeutic magic of psilocybin. He shares insights from FDA-approved trials, revealing how psychedelics can ease end-of-life distress and enhance mental well-being for terminal patients. The conversation dives into the mystical and spiritual dimensions of these experiences, redefining our understanding of consciousness and personal growth. Bossis also highlights the importance of environment and support in navigating transformative journeys, emphasizing the need for responsible psychedelic research.